Tokumoto M - Search Results

1

A case of a hemodialysis patient with secondary hyperparathyroidism who was resistant to etelcalcetide treatment but not to cinacalcet hydrochloride.

Nakamura H, Tokumoto M, Anayama M, Kurihara S, Makino Y, Tamura K, Nagasawa M. Nakamura H, et al. Among authors: tokumoto m. CEN Case Rep. 2022 May;11(2):254-258. doi: 10.1007/s13730-021-00664-0. Epub 2021 Nov 17. CEN Case Rep. 2022. PMID: 34787825 Free PMC article.

2

Blockage of the renin-angiotensin system attenuates mortality but not vascular calcification in uremic rats: sevelamer carbonate prevents vascular calcification.

Tokumoto M, Mizobuchi M, Finch JL, Nakamura H, Martin DR, Slatopolsky E. Tokumoto M, et al. Am J Nephrol. 2009;29(6):582-91. doi: 10.1159/000192844. Epub 2009 Jan 15. Am J Nephrol. 2009. PMID: 19145073

3

Effect of paricalcitol and cinacalcet on serum phosphate, FGF-23, and bone in rats with chronic kidney disease.

Finch JL, Tokumoto M, Nakamura H, Yao W, Shahnazari M, Lane N, Slatopolsky E. Finch JL, et al. Among authors: tokumoto m. Am J Physiol Renal Physiol. 2010 Jun;298(6):F1315-22. doi: 10.1152/ajprenal.00552.2009. Epub 2010 Mar 3. Am J Physiol Renal Physiol. 2010. PMID: 20200094 Free PMC article.

4

Early intervention with intravenous or pulse oral vitamin D therapy is more effective in the treatment of secondary hyperparathyroidism.

Yamada S, Taniguchi M, Tokumoto M, Tsuruya K, Hirakata H, Iida M. Yamada S, et al. Among authors: tokumoto m. Ther Apher Dial. 2010 Aug 1;14(4):424-31. doi: 10.1111/j.1744-9987.2010.00817.x. Ther Apher Dial. 2010. PMID: 20649764

5

Two Years of Cinacalcet Hydrochloride Treatment Decreased Parathyroid Gland Volume and Serum Parathyroid Hormone Level in Hemodialysis Patients With Advanced Secondary Hyperparathyroidism.

Yamada S, Tokumoto M, Taniguchi M, Toyonaga J, Suehiro T, Eriguchi R, Fujimi S, Ooboshi H, Kitazono T, Tsuruya K. Yamada S, et al. Among authors: tokumoto m. Ther Apher Dial. 2015 Aug;19(4):367-77. doi: 10.1111/1744-9987.12292. Epub 2015 Apr 7. Ther Apher Dial. 2015. PMID: 25851690 Clinical Trial.

6

[The pathophysiology of secondary hyperparathyroidism].

Tokumoto M. Tokumoto M. Clin Calcium. 2016 Jun;26(6):821-9. Clin Calcium. 2016. PMID: 27230837 Review. Japanese.

7

Predictive factors requiring high-dose evocalcet in hemodialysis patients with secondary hyperparathyroidism.

Tokumoto M, Tokunaga S, Asada S, Endo Y, Kurita N, Fukagawa M, Akizawa T. Tokumoto M, et al. PLoS One. 2022 Dec 13;17(12):e0279078. doi: 10.1371/journal.pone.0279078. eCollection 2022. PLoS One. 2022. PMID: 36512619 Free PMC article. Clinical Trial.

8

[Cell cycle progression in secondary hyperparathyroidism].

Tokumoto M, Taniguchi M, Hirakata H. Tokumoto M, et al. Fukuoka Igaku Zasshi. 2003 Jun;94(6):201-8. Fukuoka Igaku Zasshi. 2003. PMID: 12934575 Free article. Review. Japanese. No abstract available.

9

Parathyroid cell growth in patients with advanced secondary hyperparathyroidism: vitamin D receptor, calcium sensing receptor, and cell cycle regulating factors.

Tokumoto M, Taniguchi M, Matsuo D, Tsuruya K, Hirakata H, Iida M. Tokumoto M, et al. Ther Apher Dial. 2005 Aug;9 Suppl 1:S27-34. doi: 10.1111/j.1744-9987.2005.00302.x. Ther Apher Dial. 2005. PMID: 16109139 Review.

10

Persistent hyperparathyroidism in renal allograft recipients: vitamin D receptor, calcium-sensing receptor, and apoptosis.

Taniguchi M, Tokumoto M, Matsuo D, Motoyama K, Sugitani A, Kuroki S, Yotsueda H, Tsuruya K, Hirakata H, Iida M. Taniguchi M, et al. Among authors: tokumoto m. Kidney Int. 2006 Jul;70(2):363-70. doi: 10.1038/sj.ki.5001549. Epub 2006 May 31. Kidney Int. 2006. PMID: 16738533 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

250 results

Search Page